 | • レポートコード：QYR9ST04451 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：New Technology |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、エピジェネティックの世界市場について調査・分析し、エピジェネティックの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（DNA修飾酵素、RNA修飾酵素、タンパク質修飾酵素）、用途別（学術研究所、バイオテクノロジー企業、バイオ医薬品企業、診断企業、契約研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のエピジェネティック市場動向 ・主要企業別マーケットシェア ・エピジェネティックの種類別市場規模2014-2019 （DNA修飾酵素、RNA修飾酵素、タンパク質修飾酵素） ・エピジェネティックの用途別市場規模2014-2019 （学術研究所、バイオテクノロジー企業、バイオ医薬品企業、診断企業、契約研究機関） ・エピジェネティックの北米市場：主要企業・種類別/用途別市場規模 ・エピジェネティックのヨーロッパ市場：主要企業・種類別/用途別市場規模 ・エピジェネティックの中国市場：主要企業・種類別/用途別市場規模 ・エピジェネティックの日本国内市場：主要企業・種類別/用途別市場規模 ・エピジェネティックの東南アジア市場：主要企業・種類別/用途別市場規模 ・エピジェネティックのインド市場：主要企業・種類別/用途別市場規模 ・エピジェネティックの中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Illumina、Qiagen、Abcam、Merck & Co、Sigma-Aldrich、New England Biolabs、Thermo Fisher Scientific、Diagenode、Active Motif、Roche Diagnostics、Eisai、Novartis） ・エピジェネティックの市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
United States will continue to dominate the Epigenetic market for due to high availability of funding for research.
The growing government initiatives and increasing number of Biotechnology and Biopharmaceutical companies in APAC is also driving the market of epigenetic in APAC.
In 2018, the global Epigenetic market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Epigenetic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epigenetic development in United States, Europe and China.
The key players covered in this study
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
Market analysis by product type
DNA modifying Enzymes
RNA modifying Enzymes
Protein Modifying Enzymes
Market analysis by market
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Contract Research Organizations
Market analysis by Region
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Epigenetic status, future forecast, growth opportunity, key market and key players.
To present the Epigenetic development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Epigenetic are as follows:
History Year: 2018-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.2 DNA modifying Enzymes
1.4.3 RNA modifying Enzymes
1.4.4 Protein Modifying Enzymes
1.5 Market by Application
1.5.1 Global Epigenetic Market Share by Application (2018-2025)
1.5.2 Academic Research Institutes
1.5.3 Biotechnology Companies
1.5.4 Biopharmaceutical Companies
1.5.5 Diagnostic Companies
1.5.6 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Epigenetic Market Size
2.2 Epigenetic Growth Trends by Regions
2.2.1 Epigenetic Market Size by Regions (2018-2025)
2.2.2 Epigenetic Market Share by Regions (2018-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Epigenetic Revenue by Manufacturers (2018-2019)
3.2 Epigenetic Key Players Head office and Area Served
3.3 Key Players Epigenetic Product/Solution/Service
3.4 Date of Enter into Epigenetic Market
3.5 Key Players Epigenetic Funding/Investment Analysis
3.6 Global Key Players Epigenetic Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Epigenetic Market Size by Type (2018-2025)
4.2 Global Epigenetic Market Size by Application (2017-2025)
5 United States
5.1 United States Epigenetic Market Size (2018-2025)
5.2 Epigenetic Key Players in United States
5.3 United States Epigenetic Market Size by Type
5.4 United States Epigenetic Market Size by Application
6 Europe
6.1 Europe Epigenetic Market Size (2018-2025)
6.2 Epigenetic Key Players in Europe
6.3 Europe Epigenetic Market Size by Type
6.4 Europe Epigenetic Market Size by Application
7 China
7.1 China Epigenetic Market Size (2018-2025)
7.2 Epigenetic Key Players in China
7.3 China Epigenetic Market Size by Type
7.4 China Epigenetic Market Size by Application
8 Rest of World
8.1 Japan
8.1.1 Japan Epigenetic Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Epigenetic Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Epigenetic Market Analysis
8.3.2 Key Players in India
9 International Players Profiles
9.1 Illumina
9.1.1 Illumina Company Details
9.1.2 Company Description and Business Overview
9.1.3 Epigenetic Introduction
9.1.4 Illumina Revenue in Epigenetic Business (2018-2019)
9.1.5 Illumina Recent Development
9.2 Qiagen
9.2.1 Qiagen Company Details
9.2.2 Company Description and Business Overview
9.2.3 Epigenetic Introduction
9.2.4 Qiagen Revenue in Epigenetic Business (2018-2019)
9.2.5 Qiagen Recent Development
9.3 Abcam
9.3.1 Abcam Company Details
9.3.2 Company Description and Business Overview
9.3.3 Epigenetic Introduction
9.3.4 Abcam Revenue in Epigenetic Business (2018-2019)
9.3.5 Abcam Recent Development
9.4 Merck & Co
9.4.1 Merck & Co Company Details
9.4.2 Company Description and Business Overview
9.4.3 Epigenetic Introduction
9.4.4 Merck & Co Revenue in Epigenetic Business (2018-2019)
9.4.5 Merck & Co Recent Development
9.5 Sigma-Aldrich
9.5.1 Sigma-Aldrich Company Details
9.5.2 Company Description and Business Overview
9.5.3 Epigenetic Introduction
9.5.4 Sigma-Aldrich Revenue in Epigenetic Business (2017-2018)
9.5.5 Sigma-Aldrich Recent Development
9.6 New England Biolabs
9.6.1 New England Biolabs Company Details
9.6.2 Company Description and Business Overview
9.6.3 Epigenetic Introduction
9.6.4 New England Biolabs Revenue in Epigenetic Business (2017-2018)
9.6.5 New England Biolabs Recent Development
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Company Details
9.7.2 Company Description and Business Overview
9.7.3 Epigenetic Introduction
9.7.4 Thermo Fisher Scientific Revenue in Epigenetic Business (2018-2019)
9.7.5 Thermo Fisher Scientific Recent Development
9.8 Diagenode
9.8.1 Diagenode Company Details
9.8.2 Company Description and Business Overview
9.8.3 Epigenetic Introduction
9.8.4 Diagenode Revenue in Epigenetic Business (2018-2019)
9.8.5 Diagenode Recent Development
9.9 Active Motif
9.9.1 Active Motif Company Details
9.9.2 Company Description and Business Overview
9.9.3 Epigenetic Introduction
9.9.4 Active Motif Revenue in Epigenetic Business (2018-2019)
9.9.5 Active Motif Recent Development
9.10 Roche Diagnostics
9.10.1 Roche Diagnostics Company Details
9.10.2 Company Description and Business Overview
9.10.3 Epigenetic Introduction
9.10.4 Roche Diagnostics Revenue in Epigenetic Business (2018-2019)
9.10.5 Roche Diagnostics Recent Development
9.11 Eisai
9.12 Novartis
10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details
Table Epigenetic Key Market Segments
Table Key Players Epigenetic Covered
Table Global Epigenetic Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global Epigenetic Market Size Market Share by Type 2019-2025
Figure DNA modifying Enzymes Figures
Table Key Players of DNA modifying Enzymes
Figure RNA modifying Enzymes Figures
Table Key Players of RNA modifying Enzymes
Figure Protein Modifying Enzymes Figures
Table Key Players of Protein Modifying Enzymes
Table Global Epigenetic Market Size Growth by Application 2019-2025 (Million US$)
Figure Academic Research Institutes Case Studies
Figure Biotechnology Companies Case Studies
Figure Biopharmaceutical Companies Case Studies
Figure Diagnostic Companies Case Studies
Figure Contract Research Organizations Case Studies
Figure Epigenetic Report Years Considered
Table Global Epigenetic Market Size 2018-2025 (Million US$)
Figure Global Epigenetic Market Size and Growth Rate 2018-2025 (Million US$)
Table Global Epigenetic Market Size by Regions 2019-2025 (Million US$)
Table Global Epigenetic Market Size by Regions 2018-2025 (Million US$)
Table Global Epigenetic Market Share by Regions 2014-2019
Figure Global Epigenetic Market Share by Regions 2018-2025
Figure Global Epigenetic Market Share by Regions 2019-2025
Table Market Top Trends
Table Global Epigenetic Revenue by Manufacturers (2018-2019) (Million US$)
Table Global Epigenetic Market Share by Manufacturers (2018-2019)
Figure Global Epigenetic Market Share by Manufacturers in 2019
Table Global Key Players Epigenetic Funding/Investment Analysis (Million US$)
Table Global Key Players Epigenetic Valuation & Market Capitalization (Million US$)
Table Mergers & Acquisitions, Expansion Plans
Table Global Epigenetic Market Size by Type (2018-2025) (Million US$)
Table Global Epigenetic Market Share by Type (2018-2025)
Figure Global Epigenetic Market Size Share by Type (2018-2025)
Table Global Epigenetic Market Size by Application (2018-2025) (Million US$)
Table Global Epigenetic Market Size Share by Application (2018-2025)
Figure Global Epigenetic Market Size Market Share by Application (2018-2025)
Figure Global Epigenetic Revenue Market Share by Application in 2018
Figure United States Epigenetic Market Size 2018-2025 (Million US$)
Table United States Key Players Epigenetic Revenue (2018-2019) (Million US$)
Table United States Key Players Epigenetic Market Share (2018-2019)
Table United States Epigenetic Market Size by Type (2018-2025) (Million US$)
Table United States Epigenetic Market Share by Type (2018-2025)
Table United States Epigenetic Market Size by Application (2018-2025) (Million US$)
Table United States Epigenetic Market Share by Application (2018-2025)
Figure Europe Epigenetic Market Size 2018-2025 (Million US$)
Table Europe Key Players Epigenetic Revenue (2018-2019) (Million US$)
Table Europe Key Players Epigenetic Market Share (2018-2019)
Table Europe Epigenetic Market Size by Type (2018-2025) (Million US$)
Table Europe Epigenetic Market Share by Type (2018-2025)
Table Europe Epigenetic Market Size by Application (2018-2025) (Million US$)
Table Europe Epigenetic Market Share by Application (2018-2025)
Figure China Epigenetic Market Size 2018-2025 (Million US$)
Table China Key Players Epigenetic Revenue (2018-2019) (Million US$)
Table China Key Players Epigenetic Market Share (2018-2019)
Table China Epigenetic Market Size by Type (2018-2025) (Million US$)
Table China Epigenetic Market Share by Type (2018-2025)
Table China Epigenetic Market Size by Application (2018-2025) (Million US$)
Table China Epigenetic Market Share by Application (2018-2025)
Figure Market Size in Japan Epigenetic 2018-2025 (Million US$)
Figure Market Size in Southeast Asia Epigenetic 2018-2025 (Million US$)
Figure Market Size in India Epigenetic 2018-2025 (Million US$)
Table Illumina Company Details
Table Illumina Revenue in Epigenetic Business in 2018 and 2019
Table Illumina Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Epigenetic Business in 2018 and 2019
Table Qiagen Recent Development
Table Abcam Company Details
Table Abcam Revenue in Epigenetic Business in 2018 and 2019
Table Abcam Recent Development
Table Merck & Co Company Details
Table Merck & Co Revenue in Epigenetic Business in 2018 and 2019
Table Merck & Co Recent Development
Table Sigma-Aldrich Company Details
Table Sigma-Aldrich Revenue in Epigenetic Business in 2018 and 2019
Table Sigma-Aldrich Recent Development
Table New England Biolabs Company Details
Table New England Biolabs Revenue in Epigenetic Business in 2018 and 2019
Table New England Biolabs Recent Development
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Epigenetic Business in 2018 and 2019
Table Thermo Fisher Scientific Recent Development
Table Diagenode Company Details
Table Diagenode Revenue in Epigenetic Business in 2018 and 2019
Table Diagenode Recent Development
Table Active Motif Company Details
Table Active Motif Revenue in Epigenetic Business in 2018 and 2019
Table Active Motif Recent Development
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Epigenetic Business in 2018 and 2019
Table Roche Diagnostics Recent Development
Table Eisai Company Details
Table Novartis Company Details
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の診断専門酵素市場：専門的調査 Enzymes are natural biocatalysts, produced and harvested from living organisms such as plants, animals, bacteria, and fungi. Diagnostic specialty enzymes are used in low volume and high value-added applications. Applications of diagnostic specialty enzymes include clinical chemistry, molecular diagn…- 世界のヘルスケア専門酵素市場：専門的調査 Enzymes are biocatalysts and specific for accelerating various types of chemical reactions without undergoing self-changes. The global Healthcare Specialty Enzymes market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.…
- 世界の医療用特殊酵素市場：専門的調査 Enzymes are biocatalysts and specific for accelerating various types of chemical reactions without undergoing self-changes. The global Medical Specialty Enzymes market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. Th…
- 世界の植物特殊ソース酵素市場：専門的調査 Enzymes are biocatalysts and specific for accelerating various types of chemical reactions without undergoing self-changes. The global Plants Specialty Source Enzymes market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-20…
- 世界の動物由来特殊酵素市場：専門的調査 Enzymes are biocatalysts and specific for accelerating various types of chemical reactions without undergoing self-changes. The global Animals Source Specialty Enzymes market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2…